Sponsor

Biofourmis Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Biofourmis Inc. appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable SensorsNCT04191330 · lead sponsor · 2020-01-27
UNKNOWN
Serum Potassium Prediction Using Machine Learning and Single-lead ECGNCT07493798 · collaborator · 2021-03-20
WITHDRAWN
Prediction of Patient Deterioration Using Machine LearningNCT05045742 · collaborator · 2021-03-20
COMPLETED
Prediction of Expected Length of Hospital Stay Using Machine LearningNCT04784351 · collaborator · 2021-03-20
WITHDRAWN
Prediction of 30-Day Readmission Using Machine LearningNCT04849312 · collaborator · 2017-06-01
COMPLETED

Sponsor roles

collaborator4
lead sponsor1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.